Nephropathy


Also found in: Dictionary, Thesaurus, Medical, Wikipedia.
Related to Nephropathy: Diabetic nephropathy, Membranous nephropathy

nephropathy

[nə′fräp·ə·thē]
(medicine)
Any disease of the kidney.

Nephropathy

 

a general term that includes several renal disorders. Classified as nephropathies are nephropathy of pregnancy and a group of other kidney diseases that are distinguished from each other by a variety of morphological changes. This latter group of diseases includes myelogenous nephropathy, endemic, or Balkan, nephropathy, medicinally induced nephropathy, kaliopenic nephropathy, and hypercalcemic nephropathy.

REFERENCE

Osnovy nefrologii, vol. 2. Edited by E. M. Tareev. Moscow, 1972.
References in periodicals archive ?
Patients with diabetic nephropathy had slightly lower mean hemoglobin levels prior to undergoing dialysis, compared with those who had nondiabetic renal disease (10.
The earliest clinical sign of nephropathy is the detection of albumin in the urine (> 30 mg/day but <300 mg/day); this is the microalbuminuria stage.
N-acetylcysteine is an antioxidant that can scavenge reactive oxygen species and regenerate glutathione stores and has been shown to attenuate radiocontrast nephropathy when administered before the onset of renal insult5,6.
During the next several years, the existence of a specific HIV-associated nephropathy (HIVAN) was confirmed as a distinct clinicopathological entity.
Only N-acetylcysteine clearly prevented contrast-induced nephropathy.
Pulmonary capillaritis is a rare systemic manifestation of IgA nephropathy that can result in life-threatening diffuse alveolar hemorrhage.
The book is divided into two parts: The Basic Pathophysiology and Biochemistry of Diabetic Nephropathy (pp.
Furthermore, the fetal malformation rate is 25% in diabetic nephropathy patients with poor glycemic control; this can be reduced to less than 8% with prepregnancy counseling.
Bristol-Myers Squib and Sanofi-Synthelabo report the FDA approval was based on results from an Irbesartan Diabetic Nephropathy Trial which demonstrated that when patients with high blood pressure, type 2 diabetes and evidence of kidney disease were treated with Avapro the risk of progression of their nephropathy or death was 20% lower than that of the placebo group and 23% lower than the group treated with amlodipine, a calcium-channel blocker.
For sale in Japan since 1993, the drug was approved last Thursday by the Health, Labor and Welfare Ministry as therapy for nephropathy associated with type-1 diabetes, the pharmaceutical maker said in a press release.
Even when drugs and diet are able to control diabetes, the disease can lead to nephropathy and ESRD.